EU Mandarins Want To “Break Up Google” – Commissar Oettinger Strikes Again

EU Mandarins Want To “Break Up Google” – Commissar Oettinger Strikes Again

A Fount of Bad Ideas We have previously reported on the EU’s new digital commissar Mr. Oettinger, who has recently announced he wants to make an EU case against Google a “model case” for the EU’s approach to large companies serving the inter-tubes. Naturally, the entire convocation of busybodies in Brussels is all for this bizarre […]
The Gold Price And Geopolitics

The Gold Price And Geopolitics

Gold remains in a tough spot. The gold price was beaten down hard this year and it fell through its 1,180 USD technical support level not too long ago. That triggered a lot of sell orders and could put further downward pressure on the yellow precious metal. Some analysts are amazed by the beating that […]
Ferguson – What Did You Expect? A Real Jury Decision? The System Is Not Designed That Way

Ferguson – What Did You Expect? A Real Jury Decision? The System Is Not Designed That Way

Unfortunately, this is as expected as the Missouri grand jury decided not to indict a white police officer over the fatal shooting of an unarmed black teenager in August. I have explained that this need not even be racist because the grand jury system has become a joke. The government only needs to present whatever […]
Monetary Policy When The Spyglass Is Smudged: A Look At Gauging Economic Slack

Monetary Policy When The Spyglass Is Smudged: A Look At Gauging Economic Slack

by Early Elias, Helen Irvin, and Oscar Jorda – FRBSF Economic Letter, Federal Reserve Bank of San Francisco An accurate measure of economic slack is key to properly calibrating monetary policy. Two traditional gauges of slack have become harder to interpret since the Great Recession: the gap between output and its potential level, and the […]
Gold Trades In A Tight Range

Gold Trades In A Tight Range

Gold prices closed lower on Monday, giving back a portion of the previous week’s gains as the bulls continued to encounter resistance around the $1203 level. Richard Fisher’s comments about inflation and bullish sentiment in equities also weighed on the market. Richard Fisher, the president of the Federal Reserve Bank of Dallas, said “I don’t […]
What Are The Masters Of The Universe Buying?

What Are The Masters Of The Universe Buying?

You should never blindly follow the investment moves of anyone—not even masters of the universe like Carl Icahn or George Soros.  You never know what their investment game plan is or whether a stock position is part of a larger multi-stock trade. That said, I do consider guru trades a nice starting point for further research.  If investors […]
The 5 Best Large Caps

The 5 Best Large Caps

I wanted to find the 5 large cap stocks that had the most consistent upward momentum this past month. I used Barchart to sort the S&P 500 Large Cap stock index to find the stocks that had the most frequent new highs in the last month. The stocks making the cut are:  Sherwin-Williams (NYSE:SHW),  Lowe’s(NYSE:LOW),  Omnicom Group (NYSE:OMC),  Red […]
Here’s Why The Long Bond Could Be About To Blast Off

Here’s Why The Long Bond Could Be About To Blast Off

I always love hearing people say things like, “interest rates are so low they can’t go any lower!” That’s the sort of superficial thinking that gets investors into trouble and provides opportunities for those willing to look a bit deeper. So let’s take a look and see if that’s actually true – that rates are […]
Nothing Has Changed-And That’s The Problem

Nothing Has Changed-And That’s The Problem

Playing monetary games has done nothing to eliminate moral hazard. If we step back and look at the past six years since the global financial meltdown of 2008, we see that in terms of financial and political power, nothing has changed–and that’s the problem. If nothing has changed structurally, then none of the problems that caused […]
CPHD Receives FDA Clearance For Xpert Flu/RSV XC; SUPN Receives Issuance Of Fifth US Patent

CPHD Receives FDA Clearance For Xpert Flu/RSV XC; SUPN Receives Issuance Of Fifth US Patent

Cepheid (NASDAQ: CPHD) announced it has received clearance from the U.S. FDA to market its Xpert® Flu/RSV XC, an on-demand molecular test for accurate and reliable determination of Flu A, Flu B, and differentiation of RSV infection. Xpert Flu/RSV XC runs on Cepheid’s GeneXpert® System, the world’s leading molecular diagnostic platform with more than 7,500 systems […]